Sinovac Pharmaceutical Forms Strategic Alliance with Tianyu Pharmaceutical Subsidiary Nord Pharmaceutical

2025-05-01 / Read about 0 minute

Author：小编

Sinovac Pharmaceutical and Nord Pharmaceutical, a member of the Tianyu Pharmaceutical Group, have entered into a strategic partnership, centering on the exclusive overseas commercialization of Sitagliptin Phosphate Tablets in key markets such as Saudi Arabia and Algeria. This collaboration endeavors to propel Sinovac Pharmaceutical and Nord Pharmaceutical towards jointly tapping into the global diabetes medication market. By harnessing Sinovac Pharmaceutical's extensive experience in overseas commercialization and Nord Pharmaceutical's strengths in drug manufacturing, the partnership aims to enhance the accessibility of Sitagliptin Phosphate Tablets in emerging markets worldwide.

Previous page："Anxuyuan" Submits Prospectus to Hong Kong Stock E...

Next page：April Sees Monthly and Annual Rise in Average New ...

Return to List

Hot Reading

2 day ago

Meta’s V-JEPA 2 model teaches AI to understand its surroundings

2 day ago

Apple executives say new AI-powered Siri wasn’t ‘demoware,’ it just wasn’t ready to ship

2 day ago

A big list of the small and hidden features in iOS 26

2 day ago

The new version of Audi’s best-selling Q5 SUV arrives in the US